SEC Company Response from China Medical Technologies, Inc. (CIK 0001326059) — Jul 18, 2005
China Medical Technologies, Inc. (CIK 0001326059)
Date: July 18, 2005 · CIK: 0001326059 · Accession: 0001193125-05-143701
AI Filing Summary & Sentiment
File numbers found in text: 333-126630
Referenced dates: July 18, 2005
Letter
Via Edgar Division of Corporation Finance Securities and Exchange Commission Washington, D.C. Re: China Medical Technologies, Inc. Registration Statement on Form F-1 (Registration No. 333-126630)
Dear Messrs. Mancuso and Hunt:
On behalf of our client, China Medical Technologies, Inc., a company organized under the laws of the Cayman Islands (the “Company”), we are filing herewith the Company’s Amendment No. 1 to Registration Statement on Form F-1 (“Amendment No. 1”). For the ease of your reference, we will deliver to you 5 hard copies of Amendment No. 1 marked to show changes to the Registration Statement initially filed with the Securities and Exchange Commission on July 15, 2005.
If you have any questions, please do not hesitate to contact me at (+852) 2912-2503.
Best regards,
/s/ David T. Zhang
Show Raw Text
CORRESP 1 filename1.htm Transmittal letter dated July 18, 2005 July 18, 2005 Via Edgar Mr. Russell Mancuso, Branch Chief Mr. Donald C. Hunt, Attorney-Advisor Division of Corporation Finance Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: China Medical Technologies, Inc. Registration Statement on Form F-1 (Registration No. 333-126630) Dear Messrs. Mancuso and Hunt: On behalf of our client, China Medical Technologies, Inc., a company organized under the laws of the Cayman Islands (the “Company”), we are filing herewith the Company’s Amendment No. 1 to Registration Statement on Form F-1 (“Amendment No. 1”). For the ease of your reference, we will deliver to you 5 hard copies of Amendment No. 1 marked to show changes to the Registration Statement initially filed with the Securities and Exchange Commission on July 15, 2005. If you have any questions, please do not hesitate to contact me at (+852) 2912-2503. Best regards, /s/ David T. Zhang David T. Zhang of LATHAM & WATKINS LLP cc: Xiaodong Wu, Chairman and Chief Executive Officer, China Medical Technologies, Inc. Sam Tsang, Chief Financial Officer, China Medical Technologies, Inc. Shuang Zhao, Latham & Watkins LLP, Hong Kong Leiming Chen, Shearman & Sterling LLP, Hong Kong Jack Chow, KPMG, Hong Kong Kenneth Bunce, KPMG-US Capital Markets Group, Hong Kong Resident partners: Joseph A. Bevash (US), Sabrina Y. T. Maguire (US), John A. Otoshi (US), Mitchell D. Stocks (US), David Zhang (US)